Is Icecure Medical Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Icecure Medical Ltd (ICCM) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Icecure Medical Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Icecure Medical Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Icecure Medical Ltd?

Muslim investors may consider investing in Icecure Medical Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Icecure Medical Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Icecure Medical Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Icecure Medical Ltd updated?

The Shariah compliance status of Icecure Medical Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Icecure Medical Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Icecure Medical Ltd?

You can check the latest Shariah compliance status of Icecure Medical Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ICCM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 28, 2026

Report Source: 2025 Annual Report

Icecure Medical Ltd. Stock Analysis ICCM

United States Health Care Nano Cap Report: 2025 Annual

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

Key Statistics of Icecure Medical Ltd (ICCM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.22$0.24

Today's Open

$0.24

Volume

403.75K

P/E Ratio (TTM)

52 Week Range

$0.22$1.40

Market Cap

19.56M

Avg. Volume

539.83K

Dividend Yield

Financial Metrics & Statements of Icecure Medical Ltd (ICCM)

FAQ's for Icecure Medical Ltd (ICCM)

According to Musaffa’s Shariah screening methodology, Icecure Medical Ltd (ICCM) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.